Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

AAD news: antipsoriatic activity of low-dose Ontak confirmed in pilot trial

March 6, 2001

Sustained clinical activity reported in IDEC-114 phase I/II trial for psoriasis

March 6, 2001

FDA requests additional information for Dermagraft PMA

Feb. 27, 2001

Novel antipruritic agents in development at Pfizer

Feb. 23, 2001

Access reports positive phase III data for OraDisc canker sore treatment

Feb. 21, 2001

Botulinum toxin type A preparation proves safe and effective in axillary hyperhidrosis

Feb. 21, 2001

Cellegy accelerates filing for Anogesic in Canada

Feb. 21, 2001

Protopic for severe atopic dermatitis launched in U.S.

Feb. 20, 2001

Phase II trial establishes safety and optimal dose of PVAC psoriasis treatment

Feb. 19, 2001

Switch Biotech acquires delivery system for skin wounds

Feb. 15, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...